Fortrea Holdings Inc.
NASDAQ:FTREBiotechnology
-$0.07 today
- Market cap
- $1.94B
- Beta
- 2.11
- P/E (TTM)
- -3.1
- EPS (TTM)
- -$4.90
Volume 1.59M
Average 1.31M
FTRE Change in Working Capital
Cash absorbed or released by changes in receivables, inventory, payables, and other operating balances.
Fortrea Holdings Inc.NASDAQ: FTRE
Change in Working Capital · Q2 FY2026 · quarter ended Jun 2026
Change in working capital turns negative
Q2 FY2026 change in working capital was -$27.6M, compared with $10.3M a year earlier. Trailing-twelve-month change in working capital was $147.6M.
Context
- Change in working capital amounted to 4.2% of revenue in FY2025, down 9.3 pp from a year earlier.
- Change in working capital increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly change in working capital holds near -$27.6M or moves back toward the trailing-twelve-month quarterly average of $36.9M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Change in Working Capital history
USD · from the cash flow
- Latest · FY2025
- 114.7M USD
- Year-over-year change
- -68.5%
| Period | Period end | Change in Working Capital | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 114.7M | -68.5% |
| FY2024 | 2024-12-31 | 364.5M | +1255.0% |
| FY2023 | 2023-12-31 | 26.9M | +110.8% |
| FY2022 | 2022-12-31 | (248.2M) | -95.1% |
| FY2021 | 2021-12-31 | (127.2M) | — |
Change in Working Capital vs competitors
How FTRE compares with its peers on the latest reported figures
- FTRE's LTM Jun 2026 change in working capital of $147.6M is the largest of the 3 companies compared; the peer median is $50.23M.
- Its year-over-year change of +301.6% is the highest of 3, against a peer median of +57.0%.
- Change in working capital amounts to 5.5% of revenue for FTRE, versus a peer median of 3.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
FTREFortrea Holdings Inc. | LTM Jun 2026 | $147.6M | +301.6% | — | 5.5% |
| LTM Sep 2026 | $85.8M | -43.9% | -3.2% | 3.0% | |
| LTM Mar 2026 | $14.65M | +157.8% | -80.2% | 3.5% | |
| Peer median (excluding FTRE) | $50.23M | +57.0% | -41.7% | 3.3% | |
Competitors are the stored peer set for FTRE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 98M | 186.2M | (25.2M) | (271.5M) | (986.2M) |
| Depreciation & Amortization | 166.3M | 93.6M | 98M | 86.9M | 78M |
| Deferred Income Tax | (30.2M) | (16.5M) | (41.6M) | (24.6M) | (32M) |
| Stock-Based Compensation | 27.5M | 25.4M | 42.7M | 58.4M | 74.4M |
| Change in Working Capital | (127.2M) | (248.2M) | 26.9M | 364.5M | 114.7M |
| Accounts Receivables | (187.6M) | (108.4M) | (53.4M) | 309.9M | 70.9M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | (6.2M) | 24.8M | 55.3M | 7.2M | (109.9M) |
| Other Working Capital | 66.6M | (164.6M) | 25M | 47.4M | 153.7M |
| Other Non-Cash Items | 35.4M | 42.2M | 67.6M | 49.1M | 864.6M |
| Operating Cash Flow | 169.8M | 82.7M | 168.4M | 262.8M | 113.5M |
| Capital Expenditures | (26.5M) | (54.4M) | (40.3M) | (25.5M) | (25.2M) |
| Acquisitions (Net) | 0 | 0 | 0 | 276.6M | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 300K | 400K | 8.5M | 500K | 39.6M |
| Investing Cash Flow | (26.2M) | (54M) | (31.8M) | 251.6M | 14.4M |
| Debt Repayment | 0 | 0 | 1.62B | (482.7M) | (76.3M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (128.5M) | (6.3M) | (1.76B) | (15.1M) | 0 |
| Financing Cash Flow | (128.5M) | (6.3M) | (140.8M) | (497.8M) | (76.3M) |
| Effect of Forex Changes | (800K) | (6.6M) | 2.4M | (6.7M) | 4.5M |
| Net Change in Cash | 14.3M | 15.8M | (1.8M) | 9.9M | 56.1M |
| Free Cash Flow | 143.3M | 28.3M | 128.1M | 237.3M | 88.3M |
Fortrea Holdings Inc.
NASDAQ:FTRE
Intrinsic Alpha fair value
Locked
Current Price
$20.50
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.